Skip to main content

Loqtorzi 240 mg/6 mL (40 mg/mL) injection Images

Generic Name: toripalimab

This medication has been identified as Loqtorzi 240 mg/6 mL (40 mg/mL) injection. It is supplied by Coherus BioSciences, Inc.

Loqtorzi is used in the treatment of Nasopharyngeal Carcinoma and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Loqtorzi 240 mg/6 mL (40 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Loqtorzi 240 mg/6 mL (40 mg/mL) injection medicine

Loqtorzi

Generic Name
toripalimab
Strength
240 mg/6 mL (40 mg/mL) injection
Availability
Prescription only
Drug Class
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
CSA Schedule
Not a controlled drug
Labeler / Supplier
Coherus BioSciences, Inc.
National Drug Code (NDC)
70114-0340

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.